dilluns, 15 de setembre del 2014

TCT 2014: Is renal denervation dead or alive?




Is renal denervation for hypertension dead or alive? Experts agree that more studies are needed.






The efficacy of renal denervation is in doubt and should be confirmed or ruled out in treating resistant hypertension, according to an expert panel in a debate over the once high-flying technology at the Transcatheter Cardiovascular Therapeutics conference in Washington.




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/XqMAjc

Cap comentari:

Publica un comentari a l'entrada